-
公开(公告)号:US20100160340A1
公开(公告)日:2010-06-24
申请号:US12637789
申请日:2009-12-15
申请人: David A. COATES , Lawrence Mark GELBERT , John M. KNOBELOCH , Alfonso DE DIOS MAGANA , Ana DE PRADO GONZALEZ , Miriam FILADELFA DEL PRADO CATALINA , Maria Cristina GARCIA PAREDES , Eva Maria MARTIN DE LA NAVA , Maria Dolores MARTIN ORTEGA FINGER , Jose Antonio MARTINEZ PEREZ , Ana Isabel MATEO HERRANZ , Carlos PEREZ MARTINEZ , Concepcion SANCHEZ MARTINEZ
发明人: David A. COATES , Lawrence Mark GELBERT , John M. KNOBELOCH , Alfonso DE DIOS MAGANA , Ana DE PRADO GONZALEZ , Miriam FILADELFA DEL PRADO CATALINA , Maria Cristina GARCIA PAREDES , Eva Maria MARTIN DE LA NAVA , Maria Dolores MARTIN ORTEGA FINGER , Jose Antonio MARTINEZ PEREZ , Ana Isabel MATEO HERRANZ , Carlos PEREZ MARTINEZ , Concepcion SANCHEZ MARTINEZ
IPC分类号: A61K31/497 , C07D403/14 , C07D239/42 , A61K31/506 , A61P35/00
CPC分类号: C07D401/14
摘要: The present invention provides a compound of formula (I): or a pharmaceutically acceptable salt thereof which is useful in the treatment of cell proliferative diseases.
摘要翻译: 本发明提供了可用于治疗细胞增殖性疾病的式(I)化合物或其药学上可接受的盐。